Compare Vaxcyte Inc. Common Stock (PCVX) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.63B), while State Street Real Estate Select Sector SPDR ETF trades at $41.93 (market cap $7.75B). The key difference: Vaxcyte Inc. Common Stock is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, State Street Real Estate Select Sector SPDR ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and State Street Real Estate Select Sector SPDR ETF for 77 Days on average.
| PCVX | XLRE | |
|---|---|---|
Market Cap | $10.63B | $7.75B |
Volume | 1,525,205 | 7,826,350 |
Sector | Health | Sector/Thematic |
52-Week High | $73.82 | $46.01 |
52-Week Low | $40.32 | $40.01 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $9.26B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLRE trades at $41.83, down 0.21% on the day, with a mixed technical outlook showing a bullish overall signal but bearish moving averages. The ETF's expense ratio of 0.08% is a competitive advantage, though key valuation and profitability metrics are unavailable. Recent news highlights its role as a low-cost U.S. real estate ETF, with articles discussing its diversification versus global peers and performance amid interest rate volatility.
The outlook for XLRE is nuanced; it offers cost efficiency and U.S. large-cap real estate exposure, but faces headwinds from elevated interest rates and potential underperformance versus digital infrastructure ETFs. Investment opportunity lies in its income potential and inflation hedging, while risks include rate sensitivity and sector rotation. Analyst sentiment is balanced, reflecting sector-wide uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
